Charleston Laboratories, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2007-01-01

Employees: 11

Market Cap: -

Website: http://www.charlestonlabs.com

Clinical Trials

Active:0

Completed:6

Trial Phases

3 Phases

Phase 1:2

Phase 2:1

Phase 3:3

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Phase 3

3 (50.0%)

Phase 1

2 (33.3%)

Phase 2

1 (16.7%)

A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain

Phase 2

Completed

Conditions: Pain
Vomiting
Migraine
Nausea
Aura

Interventions: Other: Placebo

First Posted Date: 2019-03-18

Last Posted Date: 2019-11-01

Lead Sponsor: Charleston Laboratories, Inc

Target Recruit Count: 475

Registration Number: NCT03877718

Locations: 🇺🇸
Suncoast Clinical Research, Inc., New Port Richey, Florida, United States
🇺🇸
Harmony Clinical Research, Inc., North Miami Beach, Florida, United States
🇺🇸
Mountain View Cl inical Research, Inc., Greer, South Carolina, United States

A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV

Phase 3

Completed

Conditions: Vomiting
Nausea
Pain

Interventions: Drug: CL-108 5 mg
Drug: Placebo
Drug: Norco

First Posted Date: 2018-09-05

Last Posted Date: 2023-03-22

Lead Sponsor: Charleston Laboratories, Inc

Target Recruit Count: 349

Registration Number: NCT03657810

Locations: 🇺🇸
Arizona Research Center, Phoenix, Arizona, United States
🇺🇸
Chesapeake, Pasadena, Maryland, United States
🇺🇸
Optimal Research, Austin, Texas, United States

and more 2 locations